Ireland
--:--IST
Recruiting Observational

Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia

NCT04469517 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2020-08-10
Last updated
2024-12-06

Condition(s) studied

Hereditary Hemorrhagic Telangiectasia

Investigational drug(s) / intervention(s)

hypoxic induced factors

hypoxic induced factors: hypoxic induced factors analyzed in blood sample

Study summary

Patients with hereditary hemorrhagic telangiectasia (HHT) suffer from an inherited disorder leading to systemic vascular malformations. Mutations in several genes of the transforming growth factor (TGF)-β superfamily pathway influence angiogenesis in patients with HHT. The genetic loss of ALK1 or ENG alone are not sufficient to induce AVMs; environmental insults that could trigger angiogenesis (e.g. wounding) are also needed. In this study it will be analyzed if hypoxic induced factors could have an influence on the disease HHT.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * diagnosed HHT (genetic testing and/ or fulfill at least 3 Curacao Criteria) * older than 17 years * ability to consent Exclusion Criteria: * if inclusion Criteria are not met

Primary outcome measure(s)

  • Differences in hypoxic induced factors — 12 months
    Differences in hypoxic induced factors analyzed in blood samples from patients with HHT and healthy controls

Trial sites (1)

FacilityCityRegionStatus
University Hospital Essen Essen North Rhine-Westphalia Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04469517 on ClinicalTrials.gov ↗ ← All trials in Germany